990x120 Nov 18

Event Overview
Phenotypic screening identifies potential drug candidates based on their ability to modulate cells or organisms in a desired manner. However, phenotypic screening depends on models that can both induce pathological behavior and facilitate high throughput/high content screening. In this webinar from The Scientist, Molly Shoichet and Bridget Wagner will discuss strategies for creating such models and outline how they use them to identify agents to counter chronic diseases, such as cancer and diabetes.

Topics to be covered
  • How 3D cell culture enables predictive drug screening
  • Phenotypic screening for small molecule discovery in the beta cell
Wednesday, November 18, 2020
 
2:30 - 4:00 PM, Eastern Time


Speakers
Shoichet.png
Molly Shoichet, PhD, FRS, OC
Professor, Chemical Engineering & Applied Chemistry
Biomaterials & Biomedical Engineering
University of Toronto
Tier 1 Canada Research Chair in Tissue Engineering

Wagner.png
Bridget Wagner, PhD
Director of Pancreatic Cell Biology and Metabolic Disease
Institute Scientist
Broad Institute of MIT and Harvard

genomics.png

genomics.png

Register Now

High Content Phenotypic Screening and Analysis Enhances Drug Discovery
You must have Javascript and Cookies enabled to access this webcast.

Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this webinar. The Scientist and sponsor(s) may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these webinars free of charge for our readers.

The Scientist c/o LabX Media Group
1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801
Toll Free: 888.788.0328 | Phone: 705.528.6888
Email: privacy@the-scientist.com

Privacy Policy

© 1986-2022  The Scientist
 
The Scientist Logo_white

The Scientist needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.